About Us

Interdisciplinary Know-How

ACMIT, the “Austrian Center for Medical Innovation and Technology”, is a research and development center in the field of medical technology and has a bridging function between requirements at clinical side, basic research in medical technology at academic side and the development, implementation of products at company side.

ACMIT staff is representing competence in all related fields of medical engineering:

  • bio/mechanical/electronic/software engineering
  • chemistry, physics
  • human factors
  • regulatory affairs and quality management

Integrative Approach

ACMIT with large network of scientific and industrial partners concentrates knowledge from medicine, technology and market needs. Furthermore, new ideas and approaches are transformed into innovative new treatment options and novel products.

Certified Partner

ACMIT is an EN ISO 13485-certified partner of the medical technology industry. Our R&D services are complemented by the production of prototypes and contract manufacturing of medical devices.

ACMIT Company History

ACMIT was founded in 2005, based on a cooperation between the ARC Seibersdorf Research GmbH, the Vienna University of Technology, and the University of Applied Sciences in Wiener Neustadt. The company name at the time of foundation was Integrated Microsystems Austria GmbH. The goal was to merge the existing academic know-how on micro-systems technology and create an industrial competence center for serving the industry in different application areas.

Over time, the field of medical technology has played an increasingly important role in the company's activities, which resulted in the establishment of the COMET K1 competence center ACMIT – Austrian Center of Medical Innovation and Technology in 2010. Subsequently, the company name was changed to ACMIT Gmbh. Since 2010, ACMIT is fully dedicated to research and development of medical technology, from idea to clinical use.


Company Vision

We are the leading translational Medtech R&D center in Europe.


We offer:

  • all R&D services from idea to clinical use
  • international partner network
  • business planning support
  • IP strategy support
  • fundraising support
  • clinical trial management
  • regulatory affairs support
  • contract manufacturing
  • co-financing
  • investor network

to bring novel technology to the patient and make medical treatment safer and more efficient.

Company Mission

From idea to clinical use.


Management Board

Nikolaus Dellantoni


Chief Executive Officer

+43 2622 22859 0

Gernot Kronreif

Dipl.-Ing. Dr.techn. 

Chief Scientific Officer

+43 2622 22859 0

Christoph Strecker

Mag. Dr.phil. BA 

Chief Financial Officer

+43 2622 22859 0

Bernhard Nußbaumer

Dipl.-Ing. MAS EMBA 

Chief Business Development Officer

+43 664 3582028

Andreas Weinfurter


Quality Manager

+43 2622 22859 0

Alexandra Jischa


Executive Assistant, Human Resources

+43 2622 22859 15

Herbert Weißenböck

Dipl.-Ing. MSc. 

Chief Technology Officer

+43 664 2127628

Research Area Managers

Gernot Kronreif

Dipl.-Ing. Dr.techn. 

Autonomy in Surgery, Sensor Systems

+43 2622 22859 0

Tamás Haidegger

Dipl.-Ing. Dr.techn. 

Therapy Planning and Workflow Support, Surgical Data Science

+43 2622 22859 0


ACMIT Partner Network

The extensive network of partners helps us react to new challenges and research tasks in a very short period of time. Internationally renowned scientific partners provide cutting-edge knowledge as they are aware of the most recent trends and developments in minimally invasive interventions. Company partners add their expertise in realization of instruments and training systems and carefully consider market aspects. Finally, a group of renowned clinical partners ensures the additional benefit for the end-user in the operating room and the patient. This combination of competencies makes ACMIT an indispensable top partner in medical technology R&D.

Clinical partners have a significant share of the ACMIT scientific partner network. Their role is twofold: on the one hand they are a constant source of new
research questions, and on the other hand they play an important role for testing, verification and validation of research and development results in all project phases.

  • All
  • Company Partners
  • Memberships
  • Scientific Partners
MIT Entwicklungs-GmbH

Funding Bodies

ACMIT is supported by a broad range of regional, national and international funding agencies that foster the cooperation of industry, research institutions and clinics:


Dipl.-Ing. Nikolaus Dellantoni

Private shareholder,

Mag. Dr.phil. Christoph Strecker BA

Private shareholder,

Dipl.-Ing. Bernhard Nußbaumer MAS EMBA

Private shareholder,

Technical University of Vienna

The biggest Austrian and one of the most successful Technical Universities in Europe. ACMIT collaborates with the Institute of Sensor- and Actuator Systems and with the Institute of Materials Science and Technology.

iSYS Medizintechnik GmbH

Medical device manufacturer focused on interventional radiology, developing innovative robotic solutions for micro invasive interventions.

Lohmann & Rauscher GmbH

World-wide active leading woundcare and medical textiles company with headquarters in Vienna, Austria.

Karl Landsteiner Privatuniversität für Gesundheitswissenschaften GmbH

The KL University provides translational and clinical research in selected areas of health studies and human medicine, with a primary focus on biomedical engineering and is connected to three university hospitals in Lower Austria.


Strategy Board

The Strategy Board is composed of experts from technological, medical, clinical and management disciplines. In general, their role is conceived as strategic advisors helping the ACMIT management to take the right decisions.

Representatives of the following companies and hospitals are part of the ACMIT Strategy Board:

  • DI Nikolaus Dellantoni (ACMIT Gmbh) – Chairman of Strategy Board
  • Prof. Dr. Markus Enderle (ERBE Elektromedizin GmbH)
  • Dr. Christian Rohrer (Lohmann & Rauscher GmbH)
  • Univ. Prof. Dr. Heinz Redl (Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration)
  • Dr. Markus Oberparleiter (MED-EL Elektromedizinische Geräte GmbH)
  • Univ. Prof. Dr. med. Selman Uranüs (Medical University of Graz)
  • Dr. Klaus Woltron (Woltron)

Additionally, the funding body representatives from FFG and Austrian provinces have non-voting membership status.

Scientific Board

The Scientific Board’s role is to keep ACMIT in-line with the hot topics of scientific research in the area of minimally invasive procedures and to give valuable feedback to ACMIT’s scientific direction. The Scientific Board is composed of the ACMIT key researchers (Research Area Managers) as well as of a group of internationally renowned experts in the ACMIT related research fields. Most of the board members are also members of the Society for Medical Innovation and Technology (SMIT), a worldwide organization of top ranked experts.

Representatives of the following companies, hospitals and universities are part of the ACMIT Scientific Board:

  • Delft University of Technology, NL
  • PERK Lab – Queens University, CA
  • Children’s National Health System, Washington DC, US
  • Imperial College, London, UK
  • University Medical Centre Utrecht, NL
  • Landesklinikum Wr. Neustadt, AT
  • Hospital de Sabadell Barcelona, ES
  • Università di Roma Tor Vergata – School of Medicine, IT
  • Institute for Medical Science and Technology IMSaT, UK
  • Department of Neurosurgery – Klinikum Karlsruhe, DE
  • West German Heart Center – University Hospital Essen, DE
  • Medizinische Universität Wien, AT
  • Tirol Kliniken, AT
  • Medizinische Universität Graz, AT

Key Researchers

ACMIT key researchers are strengthened by the following internationally renowned experts:

Autonomy in Surgery
Prof. Dr. Jenny Dankelman (Delft University of Technology)
Dr. Thomas Lango (St. Olav’s Hospital / USIGT)

Sensor Systems for Diagnosis and Therapy
Prof. Dr. Wolfgang Drexler (Medical University of Vienna)
Prof. Dr. Leopold Schmetterer (Nanyang Technological University)

Therapy Planning and Workflow Support
Prof. Dr. Andreas Melzer (ICCAS – Innovation Center Computer Assisted Surgery)
Prof. Dr. Gabor Fichtinger (Queen’s University)

Strategic Projects
Prof. Dr. Gabor Fichtinger (Queen’s University)
Prof. Dr. Thomas Neumuth (ICCAS – Innovation Center Computer Assisted Surgery)

Work @ ACMIT

Attractive Place to Work

ACMIT offers unique career opportunities in medical technology. As a translational research center it bridges the gap between academy and industry. Our scientists and R&D managers integrate the requirements of clinical research and product development.

We offer close cooperation with top experts in diverse fields, excellent working conditions with high-end lab equipment and personal development perspectives.

The concept of flexible normal working hours is part of our corporate culture, furthermore a modern IT infrastructure ensures teleworking and home office possibilities.

ACMIT provides healthy balance between professional and family life. We endeavor an easier return to work of our employees following parental leave.

ACMIT has been awarded with the „workplace health promotion“ by the Austrian network for WHP (Österreichischen Netzwerk für BGF) in the years from 2021 to 2026.





The well-being of our employees is ensured through meal vouchers, on-site snacks, free fruits and coffee.

Our Team

Working at ACMIT means to join an international group of experts in interdisciplinary fields.

Our competencies encompass medical robotics and mechatronics, microsystems technology and sensor development, micro-optics and fiber optics technology, work-flow integration and automation.

Not only a strong background and profound experience in science and technology are prerequisites for a successful career at ACMIT – openness, flexibility, team spirit and communicative competence are equally required.

Gender & Diversity

Gender & Diversity

Equality, diversity and inclusion are essential core values for creating and disseminating new knowledge and for developing science into new direction. We want to create a gender-equal environment in which every member feels valued and supported in developing their potential. The ACMIT Gender Equality Plan (GEP) reflects our commitment to achieve a diverse and inclusive community.

Gender Equality Plan (GEP)

Career Opportunities

ACMIT offers career opportunities in both R&D and management. ACMIT opens up a broad range of future career possibilities at our international company and scientific partners in medical technology.

We are interested in applications of established professionals, senior and junior researchers (postdoc, PhD, diploma, M.S., B.S.) in our relevant fields of R&D.

Students are invited to perform applied research projects, hands-on-trainings and write their thesis in cooperation with one of our scientific partners. Visiting international researchers are also welcome for a certain period of time.

If you are interested in working and doing research at ACMIT please send your application including CV, list of publications and other relevant documents to alexandra.jischa@acmit.at.

Join our team and dedicate yourself to challenging, inspiring and diversified tasks in minimally invasive medical technology!


ACMIT is located in Wiener Neustadt within the Technology and Research Center TFZ, a booming and growing R&D site with three COMET competence centers ACMITAC²T and CEST. Main areas of R&D are in medical technology, sensor technology, surfaces, tribology (friction, wear, lubrication) and materials.
R&D entities in direct neighbourhood further include the Austrian Institute of Technology (AIT) - Biomedical Systems, the University of Applied Sciences Wiener Neustadt and the radiotherapy center MedAustron Regular meetings with these research units are taking place in order to identify possible synergies and cooperation options.

The region around Wiener Neustadt offers a high quality of life. The mountainous area of Schneeberg, Rax and Semmering is ideal for hiking, climbing and skiing and the Austrian capital Vienna is not far away.

Sustainable Development Goals

Sustainable Development Goals

Good health and well-being, responsible consumption and production, climate action and partnerships” are the goals, that constitute sustainability in medical technology. In its R&D acitivites ACMIT addresses in particular the following Sustainable Development Goals (SDGs):

https://acmit.at/wp-content/uploads/2024/01/E_WEB_03-1024x1024-1.pngGood Health & Well-Being
ACMIT's contribution to this sustainability goal is to develop new methods and tools for improved diagnosis and therapy. One of the main objectives behind each of ACMIT's development projects is to develop new technology that can provide reproducible and optimal patient outcome, even when such technology is being used by less experienced users. The "democratisation of therapy and treatment" is achieved through the transfer of expert knowledge via implemented system functionalities and optimised workflows. This concept makes modern therapies accessible to a large group of patients, especially in regions with less developed medical care.

https://acmit.at/wp-content/uploads/2024/01/E_WEB_04-1024x1024-1.pngQuality Education
As a leading international R&D centre, ACMIT successfully connects science and industry, enabling innovation and sustainable economic growth. To ensure a high-level education in medical engineering, ACMIT offers positions at different educational levels, e.g. internships, bachelor projects, master projects and PhD positions. Know-how is actively disseminated through scientific publications, lectures and participation in scientific events, but also through information events for the general public, such as "The Long Night of Science" and others.

https://acmit.at/wp-content/uploads/2024/01/E_WEB_05-1024x1024-1.pngGender Equality
ACMIT offers women and men equal opportunities for their professional development and has implemented an efficient set of procedures in order to support gender equality and to reach and maintain its related target numbers. More details can be found here. In terms of project design and implementation, e.g. in the framework of requirement assessment, usability evaluation, clinical investigation – gender balance will be considered as strict as possible. In particular, ACMIT pays attention to a balanced distribution of pathologies for both patient groups male and female. For common pathologies, acquired and used data sets (e.g. training data for AI algorithms) will be in full gender balance.

https://acmit.at/wp-content/uploads/2024/01/E_WEB_08-1024x1024-1.pngDecent Work & Economic Growth
The constantly growing medical technology market is one of the international driving factors for economic welfare. Technologies developed by ACMIT and its partners make an important contribution to the early detection and effective treatment of diseases. In particular for low-and-medium-income-countries medical products are developed in collaboration with representatives from these countries, giving the people there access to better medical treatment and enabling them to build up their economies. This creates new opportunities, stimulates education and leads to decent working conditions in these countries.

https://acmit.at/wp-content/uploads/2024/01/E_WEB_09-1024x1024-1.pngIndustry, Innovation & Infrastructure
Innovation is the foundation of everything we do at ACMIT to fulfill our mission: "from idea to clinical use". By working with the best in science and industry, we succeed in establishing real innovations in the medical technology market. Numerous examples (see our project references) are impressive proof of this. Additionally, ACMIT has tailored its range of services specifically to the needs of start-ups in order to supplement missing activities and thus increase their probability of success and the number of medical technology innovations. Last but not least, this also provides particular support for ACMIT's own start-ups.

https://acmit.at/wp-content/uploads/2024/01/E_WEB_10-1024x1024-1.pngReduced Inequalities
Two-thirds of the world’s population are lacking safe and timely surgical care. The launch of the Global Surgery movement in 2015 was met with great enthusiasm and encouraging first efforts by international organisations to partake in what appeared to be the next big step in global health delivery. Even if the total number of surgeries increased, most low-and-medium-income-countries (LMIC) still have very low surgical volumes. To contribute to a reduction of this inacceptable level of inequalities, a significant share of ACMIT’s strategic project budget is dealing with the development of medical technology for LMIC.

https://acmit.at/wp-content/uploads/2024/01/E_WEB_12-1024x1024-1.pngResponsible Consumption & Production
While socially oriented SDGs such as health, equality and education are well achievable for medical technology, the more environmentally oriented goals appear to be slower to take hold in this sector than in other areas. This may be due to regulatory requirements that medical devices must comply with before they can come onto the market. However, there are also several opportunities for environmental improvements in the medical device sector, that will be thoroughly investigated by ACMIT. The following aspects will be strongly considered in each development activity towards novel medical products:

• Use of sustainable materials (considering resource efficiency, low-emission production, reusability/degradability, etc)
• Reduction of packaging waste (also regarding EU Directives 94/62/EC and 2018/852)
• Increasing lifetime in order to decrease waste
• Implementing “circular economy” strategies (optimization reprocessing and recycling)

The content of this publication has not been approved by the United Nations and does not reflect the views of the United Nations or its officials or Member States.
United Nations Sustainable Development Goals

COMET - Competence Center


The COMET Center (K1) ACMIT is funded within COMET Competence Centers for Excellent Technologies by BMK, BMAW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by FFG (www.ffg.at/comet).

COMET is the program for application-oriented cutting-edge research in the Republic of Austria.

COMET competence centers work together with companies and research partners to develop solutions for future topics such as climate protection, digitization, mobility and health. This strengthens Austria as a research and business location.

 Comet Logos en

Awards and Prizes


The elements of the logo may not be changed in any way (exception: proportional scaling). Distortions, clipping, coloring, rearrangements are not allowed. Please also visit ACMIT's social media channels as shown in the footer of this website.

Media Contact

For media inquiries please contact:

Bernhard Nußbaumer

Dipl.-Ing. MAS EMBA 

Chief Business Development Officer

+43 664 3582028
Shopping Cart
Scroll to Top